Document is current
Any future updates will be listed below
-
Authors
Hwang, Sung-Min https://orcid.org/0000-0002-4868-147X
Awasthi, Deepika
Jeong, Jieun
Sandoval, Tito A. https://orcid.org/0000-0003-2705-5282
Chae, Chang-Suk
Ramos, Yusibeska
Tan, Chen
Marin Falco, Matías
Salvagno, Camilla
Emmanuelli, Alexander
McBain, Ian T.
Mishra, Bikash https://orcid.org/0000-0002-7351-2096
Ivashkiv, Lionel B. https://orcid.org/0000-0002-9951-0646
Zamarin, Dmitriy
Cantillo, Evelyn
Chapman-Davis, Eloise
Holcomb, Kevin
Morales, Diana K.
Yu, Xiaoqing
Rodriguez, Paulo C.
Conejo-Garcia, Jose R. https://orcid.org/0000-0001-6431-4074
Kaczocha, Martin https://orcid.org/0000-0002-2527-1398
Vähärautio, Anna https://orcid.org/0000-0003-4721-3954
Song, Minkyung https://orcid.org/0000-0003-2668-7528
Cubillos-Ruiz, Juan R. https://orcid.org/0000-0002-4267-4893
- License Information
-
More Information
Article History
Received: 29 November 2023
Accepted: 18 September 2024
First Online: 23 October 2024
Competing interests
: J.R.C.-R. holds patents on the targeting of ER stress responses for the treatment of disease, as well as on the use of immune modulators for OC therapy. J.R.C.-R. is a scientific consultant for Moderna, Immagene, Autoimmunity Biologic Solutions, and Emerald Bioventures, and holds stock options in Vescor Therapeutics. D.Z. reports institutional grants from Merck, Genentech, AstraZeneca, Plexxikon, and Synthekine, and personal fees from AstraZeneca, Xencor, Memgen, Takeda, Synthekine, Immunos, Tessa Therapeutics, Miltenyi, and Calidi Biotherapeutics. D.Z. owns a patent on use of oncolytic Newcastle Disease Virus for cancer therapy. J.R.C.-G. has stock options in Compass Therapeutics, Anixa Biosciences, and Alloy Therapeutics; receives licensing fees from Anixa Biosciences for the patent of FSHCER T cells; receives honorarium from Alloy Therapeutics; has intellectual property with Compass Therapeutics and Anixa Biosciences; and is co-founder of Cellepus Therapeutics, a company that develops allogeneic γδ CAR T cells. All other authors declare no potential conflicts of interest.
